In the original article, there was a mistake in Figures 1, 2 as published. The order of the figures was reversed while the legends of these figures were correct.
Figure 1
Figure 2
The corrected Figures 1, 2 appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
cell therapy, growth factor, immobilization, stem cell factor, cost-of-goods, cell product manufacturing
Citation
Enriquez-Ochoa D, Robles-Ovalle P, Mayolo-Deloisa K and Brunck MEG (2020) Corrigendum: Immobilization of Growth Factors for Cell Therapy Manufacturing. Front. Bioeng. Biotechnol. 8:821. doi: 10.3389/fbioe.2020.00821
Received
24 June 2020
Accepted
26 June 2020
Published
31 July 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
8 - 2020
Updates
Copyright
© 2020 Enriquez-Ochoa, Robles-Ovalle, Mayolo-Deloisa and Brunck.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Karla Mayolo-Deloisa kmayolo@tec.mxMarion E. G. Brunck marion.brunck@tec.mx
This article was submitted to Preclinical Cell and Gene Therapy, a section of the journal Frontiers in Bioengineering and Biotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.